PRELLIS Trademark

Trademark Overview

On Thursday, November 12, 2020, a trademark application was filed for PRELLIS with the United States Patent and Trademark Office. The USPTO has given the PRELLIS trademark a serial number of 90316054. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, September 30, 2024. This trademark is owned by Prellis Biologics, Inc.. The PRELLIS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research and development in the fields of tissue engineering and antibody discovery; biological research and analysis; pharmaceutical research and development; scientific and technological consulting services and research and design relating thereto in the fields of cell biology and life science research; research, design and development of tools for tissue testing; research, design and development of instruments and devices for cell research; research, design and development for instruments and devices for 3D bioprinting; research, design and development of tools for laser-based printing of biologic products, biological tissues and proteins; research, design and development of pharmaceuticals for the treatment of viral related diseases and disorders; research, design and development of pharmaceuticals for the treatment of tumors; research, design and development of 3D bioprinted lymph nodes for the production of antibodies being research, design and development services in ...
prellis

General Information

Serial Number90316054
Word MarkPRELLIS
Filing DateThursday, November 12, 2020
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, September 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 6, 2024

Trademark Statements

Goods and ServicesScientific research and development in the fields of tissue engineering and antibody discovery; biological research and analysis; pharmaceutical research and development; scientific and technological consulting services and research and design relating thereto in the fields of cell biology and life science research; research, design and development of tools for tissue testing; research, design and development of instruments and devices for cell research; research, design and development for instruments and devices for 3D bioprinting; research, design and development of tools for laser-based printing of biologic products, biological tissues and proteins; research, design and development of pharmaceuticals for the treatment of viral related diseases and disorders; research, design and development of pharmaceuticals for the treatment of tumors; research, design and development of 3D bioprinted lymph nodes for the production of antibodies being research, design and development services in the field of antibodies

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 12, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePrellis Biologics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHayward, CA 94545
Party NamePrellis Biologics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHayward, CA 94545

Trademark Events

Event DateEvent Description
Monday, November 16, 2020NEW APPLICATION ENTERED
Tuesday, January 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 18, 2021NON-FINAL ACTION WRITTEN
Tuesday, March 16, 2021ASSIGNED TO EXAMINER
Thursday, March 18, 2021NON-FINAL ACTION E-MAILED
Thursday, March 18, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 16, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 16, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 17, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, October 10, 2021SUSPENSION LETTER WRITTEN
Sunday, October 10, 2021LETTER OF SUSPENSION E-MAILED
Sunday, October 10, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, May 20, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, January 27, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, February 16, 2023NON-FINAL ACTION WRITTEN
Thursday, February 16, 2023NON-FINAL ACTION E-MAILED
Thursday, February 16, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 3, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 3, 2023DIVISIONAL REQUEST RECEIVED
Wednesday, May 3, 2023TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, September 20, 2023ASSIGNED TO LIE
Tuesday, October 10, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 6, 2023DIVISIONAL PROCESSING COMPLETE
Tuesday, November 7, 2023NON-FINAL ACTION WRITTEN
Tuesday, November 7, 2023NON-FINAL ACTION E-MAILED
Tuesday, November 7, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 8, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 13, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 3, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 6, 2024PUBLISHED FOR OPPOSITION
Tuesday, February 6, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 2, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 7, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 30, 2024SOU TEAS EXTENSION RECEIVED
Monday, September 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 30, 2024SOU EXTENSION 1 GRANTED
Monday, September 30, 2024SOU EXTENSION 1 FILED
Tuesday, May 7, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 7, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

prellis research development design services scientific tools fields cell treatment instruments